8 Red Flags of New Biotechs
Thu, Oct 22, 2009
Derek Lowe submits:
Xconomy has a useful two-part interview with Christopher Henney, who helped to found Icos (ICOS), Dendreon (DNDN), and Immunex. The part I found most interesting, naturally, was the section entitled "Five Red Flags of Biotech". (Note to the Xconony folks – the article actually has six of them). Here are his warning signs if you’re thinking of investing in (or, I should add, working for!) a new company and you’re checking them out. Beware of. . .
1. Top management without a scientific background. If the CEO isn’t a scientist, Henney says, there had better be some good ones very close to him, and he’s not talking about the scientific advisory board, either.









Leave a Reply